Matches in Wikidata for { <http://www.wikidata.org/entity/Q82039468> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q82039468 description "article scientifique publié en 2011" @default.
- Q82039468 description "artículu científicu espublizáu n'ochobre de 2011" @default.
- Q82039468 description "im Oktober 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82039468 description "scientific article published on 05 October 2011" @default.
- Q82039468 description "wetenschappelijk artikel" @default.
- Q82039468 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q82039468 name "Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form" @default.
- Q82039468 name "Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form" @default.
- Q82039468 type Item @default.
- Q82039468 label "Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form" @default.
- Q82039468 label "Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form" @default.
- Q82039468 prefLabel "Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form" @default.
- Q82039468 prefLabel "Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form" @default.
- Q82039468 P1433 Q82039468-5657F80D-FD90-4DEB-BD76-926C973FC533 @default.
- Q82039468 P1476 Q82039468-CAAE6E48-2DC9-40B8-AF0F-E45ED986A7CB @default.
- Q82039468 P2093 Q82039468-28EED00E-59B5-4BC2-BF14-8F02D362AA83 @default.
- Q82039468 P2093 Q82039468-35B27F34-4CE4-4897-9D8D-B70CC0C94E12 @default.
- Q82039468 P2093 Q82039468-6CD906AD-D82A-4F80-82DA-13250745FA64 @default.
- Q82039468 P2093 Q82039468-A338C637-25BA-4D77-B9A5-95A8638CF5BE @default.
- Q82039468 P2093 Q82039468-CDF13C10-20AF-4046-AB43-92AFFB6980A2 @default.
- Q82039468 P2093 Q82039468-D1016C2D-D2FC-41CE-9A2D-B946051AB3D5 @default.
- Q82039468 P2093 Q82039468-E5950E40-7525-4810-B156-2B82FF8627BE @default.
- Q82039468 P304 Q82039468-CC58E350-CAD1-420F-9ED1-594A23F6DF1A @default.
- Q82039468 P31 Q82039468-E6A15017-A53E-4782-A7D7-E387BE5188E5 @default.
- Q82039468 P356 Q82039468-86C03288-7939-4720-8BEF-D89B819DA8ED @default.
- Q82039468 P433 Q82039468-85FFE822-91E3-41AC-B16C-FD7C377F0BC1 @default.
- Q82039468 P478 Q82039468-98A488C7-ADE1-494E-9278-791E1621CC32 @default.
- Q82039468 P577 Q82039468-2B6A5483-85A9-4D2C-B656-C17D80AA4856 @default.
- Q82039468 P698 Q82039468-A429EEEA-72A8-48B3-B035-D8FDC7E504C1 @default.
- Q82039468 P921 Q82039468-C1874A68-C917-43BD-B368-D949CD4EA56A @default.
- Q82039468 P356 J.IJPHARM.2011.09.046 @default.
- Q82039468 P698 22001539 @default.
- Q82039468 P1433 Q6051539 @default.
- Q82039468 P1476 "Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form" @default.
- Q82039468 P2093 "Hiroaki Nakagami" @default.
- Q82039468 P2093 "Hiroshi Kikuchi" @default.
- Q82039468 P2093 "Mitsuru Akashi" @default.
- Q82039468 P2093 "Shinji Sakuma" @default.
- Q82039468 P2093 "Shinji Yamashita" @default.
- Q82039468 P2093 "Taro Kanamaru" @default.
- Q82039468 P2093 "Yoshimine Fujii" @default.
- Q82039468 P304 "244-251" @default.
- Q82039468 P31 Q13442814 @default.
- Q82039468 P356 "10.1016/J.IJPHARM.2011.09.046" @default.
- Q82039468 P433 "2" @default.
- Q82039468 P478 "421" @default.
- Q82039468 P577 "2011-10-05T00:00:00Z" @default.
- Q82039468 P698 "22001539" @default.
- Q82039468 P921 Q461809 @default.